Company & Sponsor Intelligence

IRCCS Eugenio Medea

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials8

Recruiting3

Completed3

Countries1

Therapeutic footprint

adhdautismcerebral_palsyepilepsyother_psychiatry

Indexed studies

NCT06900400Sustained Endogenous Attention Deficits in Attention Deficit Hyperactivity Disorder
adhd · ItalyNA

NCT04769011Motor Impairments in Children With Autism Spectrum Disorder: a Multimodal Approach
autism · ItalyNA

NCT07240740WittyChildren - Advanced Technology for Response Time Evaluation in Children Affected by Developmental Disorders
cerebral_palsy · ItalyCOMPLETED

NCT04272021Multi Neuro-functional Biomarkers for Monitoring the Effects of Treatments in ADHD Children
adhd · ItalyPHASE4

NCT06544824Accuracy Comparison: Optoelectronic Motion Capture and Markerless System
other_psychiatry · ItalyACTIVE_NOT_RECRUITING

NCT05015868Contribution of Genetics, Non-invasive Methods and Neuropsychology in Focal Cryptogenic Epilepsies
epilepsy · ItalyNA

NCT07470138Sleep Disturbance in Subjects With Autism Spectrum Disorders (ASD) in Preschool Age (18-60 Months)
autism · ItalyRECRUITING

NCT06337383Study of the Prevalence of Autistic Traits in Angelman Syndrome
autism · ItalyUNKNOWN

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →